Fundz

Ora Biomedical reported raising $205,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATENov 13, 2026Late filing, first sale Jan 19, 2026$205K of $1M raised

Amount Raised

$205,000

$205,000 sold, per SEC Form D (first sale Jan 19, 2026)

Round Type

Pre-Seed

SeattleInformation TechnologyBiotechnology Research

Quick answer

Ora Biomedical raised $205,000 in a Pre-Seed round, dated January 19, 2026. Ora Biomedical is based in Seattle, Washington, United States.

How much did Ora Biomedical raise?
Ora Biomedical raised $205,000 in a Pre-Seed round on January 19, 2026.
What does Ora Biomedical do?
Ora Biomedical, Inc. is a new pharmaceutical company in the longevity biotechnology sector that identifies and characterizes healthy aging therapeutics for further clinical and commercial development.
Where is Ora Biomedical based and how big is it?
Ora Biomedical is based in Seattle, Washington, United States.
Who are the decision-makers at Ora Biomedical?
Fundz holds 1 contact at Ora Biomedical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology Research around the same time

Companies in the same sectors as Ora Biomedical that raised within 45 days of this round, from Fundz verified event records.

  • Peptris Technologies raised $7.7M (Series A) on February 18, 2026.

Who to call at Ora Biomedical, and when

A new round usually means Ora Biomedical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ora Biomedical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ora Biomedical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ora Biomedical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ora Biomedical

Location

Seattle, Washington, United States

About

Ora Biomedical, Inc. is a new pharmaceutical company in the longevity biotechnology sector that identifies and characterizes healthy aging therapeutics for further clinical and commercial development. Ora Biomedical separates itself from other longevity biotech companies by building in large-scale drug discovery and validation at the core of our scientific operations. With robust preclinical discovery at the heart of our approach, we identify novel aging targets and new interventions for known targets. Most importantly, we will leverage large-scale operations to perform drug studies that combine known and novel healthy aging interventions to identify those that produce breakthrough increases in healthy lifespan and/or mitigate disease-mediated pathology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ora Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Ora Biomedical's next move

See what Strategic adds

Ora Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.